Skip to main content

IL-4: Proteins and Enzymes

IL-4 (Interleukin-4) is a cytokine that is primarily expressed by Th2-biased CD4+ T cells, mast cells, basophils, and eosinophils. It promotes cell proliferation, survival, and immunoglobulin class switch to IgG4 and IgE in human B cells, acquisition of the Th2 phenotype by naïve CD4+ T cells, priming and chemotaxis of mast cells, eosinophils, and basophils, and the proliferation and activation of epithelial cells. IL-4 plays a dominant role in the development of allergic inflammation and asthma. The type I receptor for IL-4, which is expressed on hematopoietic cells, is a heterodimer of the ligand binding IL-4 R alpha and the common gamma chain (a shared subunit of the receptors for IL-2, -7, -9, -15, and -21). The type II receptor on nonhematopoietic cells consists of IL-4 R alpha and IL-13 R alpha 1. The type II receptor also transduces IL-13 mediated signals. 

Show More

25 results for "IL-4 Proteins and Enzymes" in Products

IL-4: Proteins and Enzymes

IL-4 (Interleukin-4) is a cytokine that is primarily expressed by Th2-biased CD4+ T cells, mast cells, basophils, and eosinophils. It promotes cell proliferation, survival, and immunoglobulin class switch to IgG4 and IgE in human B cells, acquisition of the Th2 phenotype by naïve CD4+ T cells, priming and chemotaxis of mast cells, eosinophils, and basophils, and the proliferation and activation of epithelial cells. IL-4 plays a dominant role in the development of allergic inflammation and asthma. The type I receptor for IL-4, which is expressed on hematopoietic cells, is a heterodimer of the ligand binding IL-4 R alpha and the common gamma chain (a shared subunit of the receptors for IL-2, -7, -9, -15, and -21). The type II receptor on nonhematopoietic cells consists of IL-4 R alpha and IL-13 R alpha 1. The type II receptor also transduces IL-13 mediated signals. 

Show More

25 results for "IL-4 Proteins and Enzymes" in Products

Applications: BA

Analyzed by SEC-MALS

Applications: BA
Applications: BA

Intended for preclinical researchers who may transition to GMP IL-4 for their clinical work

Applications: BA
Applications: BA
Applications: BA
Applications: BA
Applications: BA
Applications: BA
Applications: BA
Applications: BA
Applications: BA
Applications: BA
Applications: BA
Catalog #: NBP2-76270
Applications: Bioactivity, PAGE
Catalog #: NBP2-76286
Applications: Bioactivity, PAGE
Catalog #: NBP2-76290
Applications: Bioactivity, PAGE
Applications: PAGE, Bioactivity
Catalog #: NBP2-52393
Applications: Bioactivity, PAGE
Applications: PAGE, Bioactivity
Applications: PAGE, Bioactivity
Applications: PAGE, Bioactivity
Applications: PAGE, Bioactivity
Applications: BA
Applications: BA
Results Per Page
5 10 25 50
/ 1